Impact Factor
2.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.60
141 total citations
h5-index
15
h5 depth signal
Cited share
41.0%
96 of 234
Total citations
141
Citation footprint
Metric signal
0.65
External metric anchor
Self-citation
0.7%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,384
Portugal
80
Spain
78
Brazil
51
Turkey
27
Citing Fields of Research
Dermatology
1,269
Allergies
345
Auto-Inflammatory Disorders
311
Oncology
200
Health Education & Remote Healthcare
151
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,593
Articles tracked across the journal lifetime
Indexed publication set
234
96 cited publications
Last 12 months
126
25.2 publications/month
Open access share
100.0%
126 OA publications in the last year
Leading citing country
United States
1,384 citing publications
Leading citing field
Dermatology
1,269 citing publications
Latest tracked publication
6 July 2026
10 recent records available
Coverage & Indexing History
v3n1,Aug. 1997-
v3n1,Aug. 1997-
Active Coverage
Research Focus & Classification
Indexed Subjects
Dermatology
Issuing & Sponsoring Bodies
Contributor
University of California, Davis
Broad Categories
Dermatology
Auto-Inflammatory Disorders
Allergies
Musculoskeletal Disorders
Epithelial Barriers
Musculoskeletal & Nerve Cancer
MeSH Descriptors
Dermatology
Skin Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.25251/nke1113l
Open DOI
GZ21T as an emerging topical dermatologic therapy: A literature review
Background: Chronic and treatment-resistant dermatologic disorders remain difficult to manage with current therapies because of incomplete efficacy, tolerability limitations, and long-term safety concerns. GZ21T is a topical formulation ...
02
DOI 10.25251/79p6zp62
Open DOI
A scoping review: Community-based interventions for primary prevention of skin cancer
Background: Skin cancer remains one of the most preventable yet prevalent malignancies worldwide, with non-melanoma and melanoma skin cancers ranking among the top 5 and top 20 most common cancers, respectively. Rising incidence rates in...
03
04
DOI 10.25251/fpzgo476
Open DOI
Microbiome dysbiosis in psoriatic skin among Asian populations:Insights from a systematic review and meta-analysis
Background: Psoriasis is a chronic immune-mediated skin disease increasingly associated with microbial dysbiosis. Objective: To clarify patterns of skin microbiome alteration in psoriasis. Methods: We conducted a systematic review and me...
05
06
07
DOI 10.25251/cwvjt950
Open DOI
Treatment patterns for bullous pemphigoid in older adults: A population-based study
Background:Bullous pemphigoid (BP) is a chronic autoimmune blistering disease that disproportionately affects older adults and is associated with substantial morbidity, mortality, and treatment-related risks. Despite an expanding therape...
08
DOI 10.25251/ha2gbq97
Open DOI
The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panel
Background: Inflammatory skin diseases, including psoriasis and atopic dermatitis, require long-term management strategies that balance efficacy with safety. The 2025 American Academy of Dermatology guidelines encourage the judicious app...
09
10
DOI 10.25251/cbt3nw51
Open DOI
Use of dermoscopy in patients with dark skin phototypes: Practices,challenges, and diagnostic value
Background: Dermoscopy is an essential diagnostic tool in dermatology; however, its application in patients with dark skin phototypes remains insufficiently explored. Objective: To assess dermatologists’ practices, perceptions, and chall...
Bibliographical & Catalog Notes
Title from title screen (viewed Mar. 23, 1998).
Vol. 2, published in 1996, completes in one issue.
Text (electronic journal)
Mode of access: Internet.